229 related articles for article (PubMed ID: 17650334)
1. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Taylor JA; Kuchel GA; Hegde P; Voznesensky OS; Claffey K; Tsimikas J; Leng L; Bucala R; Pilbeam C
BMC Cancer; 2007 Jul; 7():135. PubMed ID: 17650334
[TBL] [Abstract][Full Text] [Related]
2. Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
Taylor JA; Zhu Q; Irwin B; Maghaydah Y; Tsimikas J; Pilbeam C; Leng L; Bucala R; Kuchel GA
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1343-53. PubMed ID: 16835407
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.
Choudhary S; Hegde P; Pruitt JR; Sielecki TM; Choudhary D; Scarpato K; Degraff DJ; Pilbeam CC; Taylor JA
Carcinogenesis; 2013 Dec; 34(12):2891-9. PubMed ID: 23825153
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
Guo YS; Dai YP; Li W; Liu LD
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):28-31. PubMed ID: 21575460
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.
Taylor JA; Ristau B; Bonnemaison M; Voznesensky OS; Hegde P; Kuchel GA; Pilbeam CC
Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):36-41. PubMed ID: 18834948
[TBL] [Abstract][Full Text] [Related]
6. Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.
Bay-Richter C; Janelidze S; Sauro A; Bucala R; Lipton J; Deierborg T; Brundin L
J Neuroinflammation; 2015 Sep; 12():163. PubMed ID: 26338025
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein suppresses bladder carcinogenesis.
Nishizawa K; Nishiyama H; Matsui Y; Kobayashi T; Saito R; Kotani H; Masutani H; Oishi S; Toda Y; Fujii N; Yodoi J; Ogawa O
Carcinogenesis; 2011 Oct; 32(10):1459-66. PubMed ID: 21771725
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor mediates protease-activated receptor 4-induced bladder pain through urothelial high mobility group box 1.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Hunt DE; Leng L; Bucala R; Vera PL
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263120
[TBL] [Abstract][Full Text] [Related]
9. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
11. The critical role of macrophage migration inhibitory factor in insulin activity.
Vujicic M; Senerovic L; Nikolic I; Saksida T; Stosic-Grujicic S; Stojanovic I
Cytokine; 2014 Sep; 69(1):39-46. PubMed ID: 25022960
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
[TBL] [Abstract][Full Text] [Related]
13. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation.
Yoshihisa Y; Makino T; Matsunaga K; Honda A; Norisugi O; Abe R; Shimizu H; Shimizu T
J Invest Dermatol; 2011 Apr; 131(4):925-31. PubMed ID: 21191413
[TBL] [Abstract][Full Text] [Related]
16. Role of MIF1/MIF2/CD74 interactions in bladder cancer.
Woolbright BL; Rajendran G; Abbott E; Martin A; Amalraj S; Dennis K; Li X; Warrick J; Taylor JA
J Pathol; 2023 Jan; 259(1):46-55. PubMed ID: 36214539
[TBL] [Abstract][Full Text] [Related]
17. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
Chuang JJ; Dai YC; Lin YL; Chen YY; Lin WH; Chan HL; Liu YW
Toxicol Appl Pharmacol; 2014 Sep; 279(3):322-330. PubMed ID: 24998975
[TBL] [Abstract][Full Text] [Related]
20. Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Zhu C; Liu Y; Song Y; Wang Q; Liu Y; Yang S; Li D; Zhang Y; Cheng B
Biomed Pharmacother; 2020 May; 125():109919. PubMed ID: 32062385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
